Chembio Diagnostics develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The Company's products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, a DPP HIV-Syphilis multiplex test, and a test for the detection of Hepatitis-C. Chembio Diagnostics sells its products under a number of brands and labels. The Company has collaboration agreements to develop POC diagnostic tests for traumatic brain injury, a specific type of cancer and an undisclosed biomarker.

TypePublic
HQMedford, US
Founded1985
Size (employees)131 (est)
Websitechembio.com
Chembio was founded in 1985 and is headquartered in Medford, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Chembio

John Sperzel

John Sperzel

President and Chief Executive Officer

Chembio Office Locations

Chembio has an office in Medford
Medford, US (HQ)
3661 Horseblock Road
Show all (1)
Report incorrect company information

Chembio Financials and Metrics

Chembio Revenue

Embed Graph
Chembio's revenue was reported to be $24.02 m in FY, 2017
USD

Revenue (Q2, 2018)

16.4m

Gross profit (Q2, 2018)

6.4m

Gross profit margin (Q2, 2018), %

38.8%

Net income (Q2, 2018)

(2.4m)

EBIT (Q2, 2018)

(2.4m)

Market capitalization (11-Oct-2018)

141.6m

Closing stock price (11-Oct-2018)

10.0

Cash (30-Jun-2018)

9.5m

EV

132.5m
Chembio's current market capitalization is $141.6 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

29.5m27.6m24.3m17.9m24.0m

Revenue growth, %

(6%)(12%)(26%)

Cost of goods sold

17.2m16.8m13.8m9.4m12.9m

Gross profit

12.3m10.8m10.5m8.5m11.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

9.6m5.8m7.4m7.3m6.2m6.7m6.9m6.6m3.3m3.7m6.3m4.1m7.7m16.4m

Cost of goods sold

5.6m3.5m4.4m4.7m3.5m3.7m4.0m3.4m1.7m1.8m3.2m2.2m4.1m10.1m

Gross profit

4.1m2.3m3.0m2.7m2.7m3.0m2.9m3.2m1.6m2.0m3.1m1.9m3.6m6.4m

Gross profit Margin, %

42%39%40%36%43%45%42%48%48%52%49%46%47%39%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

9.7m4.6m5.4m10.6m3.8m

Accounts Receivable

525.6m

Inventories

3.2m3.6m3.6m3.3m4.4m

Current Assets

18.5m17.7m12.6m18.1m10.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

8.0m9.1m6.8m3.7m2.8m1.6m1.1m2.7m1.4m12.2m5.6m3.7m12.5m9.5m

Inventories

3.7m3.6m4.1m4.0m3.7m3.8m3.0m3.4m3.5m3.4m3.8m5.0m5.8m6.3m

Current Assets

18.0m17.2m17.5m17.0m16.2m15.7m15.2m12.0m10.4m20.6m15.9m14.1m22.9m23.5m

PP&E

1.8m1.9m2.1m2.1m3.0m2.8m2.6m2.2m2.0m1.8m1.9m2.1m1.9m2.4m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

530.8k(1.1m)(2.4m)(13.3m)(6.4m)

Depreciation and Amortization

607.8k739.3k1.4m1.1m1.3m

Inventories

(700.7k)(449.6k)60.3k242.8k(1.1m)

Accounts Payable

182.5k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

716.7k(224.7k)(146.0k)(270.6k)(303.6k)(8.3m)(2.1m)(1.6m)(652.3k)(2.4m)

Depreciation and Amortization

223.0k446.6k

Inventories

4.1m4.0m3.7m3.8m3.0m3.4m3.5m3.4m3.8m(1.4m)(1.9m)

Accounts Payable

1.3m3.0m
USDY, 2018

EV/EBIT

-55 x

EV/CFO

-26.1 x

Financial Leverage

1.3 x
Show all financial metrics

Chembio Operating Metrics

FY, 2016

Patents (US)

4

Products

3
Show all operating metrics

Chembio Revenue Breakdown

Embed Graph

Chembio revenue breakdown by geographic segment: 35.6% from South America, 37.2% from North America, 8.3% from Europe, 17.3% from Africa and 1.7% from Other

Report incorrect company information

Chembio Online and Social Media Presence

Embed Graph
Report incorrect company information

Chembio News and Updates

Chembio Receives $10.5 Million Commitment from Bio-Manguinhos for Production of DPP® Assays in Brazil

MEDFORD, N.Y., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received a $10.5 million commitment from Bio-Manguinhos to purchase test components and intermediate prod…

Chembio Diagnostics Reports Second Quarter 2018 Financial Results

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic testing, today reported financial results for the second quarter ended June 30, 2018.

Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test

MEDFORD, N.Y. and GENEVA, July 28, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced a collaboration with the Foundation for Innovative New Diagnostics (FIND) to expedite the feasibility testing of a rapid diagno…

Zika Virus Testing Market reach 120 million US$ by the end of 2025

The global Zika Virus Testing market is valued at 96 million US$ in 2017 and will reach 120 million US$ by the end of 2025, growing at a CAGR of 3.1% during 2018-2025. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

Chembio Blogs

R&D Project Director

Job Title: R&D Project Director Department: Research & Development Reports To: VP & CSTO/VP Pay Classification: Exempt Position Summary: The R&D Project Director is responsible for managing key R&D projects. Project management responsibilities include the coordination of key…

Director of Manufacturing and Technical Operations

Job Title: Director of Manufacturing and Technical Operations Department: Operations Reports To: Chief Operating Officer Pay Classification: Exempt Position Summary: Oversees and directs all manufacturing operations, including the quality of all goods produced. Using process, quality and produc…

Junior Scientist

Job Title: Junior Scientist Department: Research & Development Reports To: R&D Scientist or Director Pay Classification: Exempt Position Summary: The Junior Scientist is responsible for performing experiments to develop and refine state-of-the-art assays for the detection of infectious d…

Senior Research & Development Scientist

Job Title: Senior Research & Development Scientist Department: Research & Development Reports To: Director of Research and Development or SVP R&D Pay Classification: Exempt Position Summary: This position is responsible for planning, organizing and performing experiments to develop a…

Lead Facilities Maintenance Mechanic (2nd shift only)

Job Title: Lead Facilities Maintenance Mechanic (2nd shift only) Department: Operations Reports To: Sr. Manager, Facilities & Maintenance Pay Classification: Hourly Position Summary: The Lead Facilities Maintenance Mechanic is responsible for facility infrastructure, and performing preventa…

QA Inspector (1st and second shift)

Job Title: QA Inspector (1st and second shift) Department: Quality Assurance Reports To: QA Supervisor Pay Classification: Non-Exempt Position Summary: Inspect raw materials, packaging components, labels and finished product to ensure conformance to specifications and review batch records for co…

Chembio Company Life and Culture

Report incorrect company information